Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!


More On

Bayer settles claims of gallbladder injury caused by Yasmin and Yaz contraceptives

The company will pay $24 million, but can walk away if fewer than 90 percent of those eligible opt in

Earlier this month, Bayer AG designated $1.5 billion for litigation related to its Yasmin and Yaz contraceptive pills, and now it looks like the company will be dipping into that fund. On Friday, Bayer agreed to pay $24 million to settle claims from plaintiffs in Illinois, California, New Jersey and Pennsylvania that Yasmin and Yaz caused them to suffer gallbladder injuries.

Under the deal, plaintiffs whose gallbladders were injured will receive $2,000, and plaintiffs whose gallbladders were removed will receive $3,000. The settlement is capped at $24 million, however, so depending on how many people file claims, the payments may be lower. The terms of the agreement also allow Bayer to walk away if fewer than 90 percent of eligible individuals opt into the settlement.

Since 2009, Bayer has been hit with more than 10,000 articles alleging failure to warn of health issues that result from the use of Yasmin and Yaz, according to its annual report filed in February. The report also stated that the company has reached agreements to pay $1 billion to settle 4,800 claims that the birth control pills cause blood clots. However, women who collect the gallbladder settlement will not be able to collect the blood clot settlement, Thomson Reuters reports.

The company did not admit liability as part of the settlement, and maintains that it does not believe the birth control pills increase risk of gallbladder disease.


For more InsideCounsel coverage of birth control lawsuits, see below:

Bayer designates $1.5 billion for litigation over Yasmin and Yaz contraceptives

Court denies contraception coverage injunction

Birth control exemptions fail to stop lawsuits

Hobby Lobby loses appeal of contraception coverage

Hobby Lobby sues not to cover morning-after pill

Novartis unit recalls birth control pills

Woman sues birth control pill maker for unintended pregnancy

Join the Conversation

Advertisement. Closing in 15 seconds.